Average Co-Inventor Count = 1.93
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Warner-Lambert Company (24 from 2,538 patents)
2. Other (1 from 832,912 patents)
3. Warner Lambert LLC (1 from 22 patents)
26 patents:
1. 7101886 - Phenylalkyl and pyridylalkyl piperazine derivatives
2. 6919377 - Cyclohexylamine derivative as subtype selective NMDA receptor antagonists
3. 6828341 - Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists
4. 6794402 - Bicyclic cyclohexylamines and their use as NMDA receptor antagonists
5. 6765022 - Cyclohexylamine derivatives as subtype selective nmda receptor antagonists
6. 6683101 - Bicyclic cyclohexylamines and their use as NMDA receptor antagonists
7. 6642256 - Piperidine derivatives as subtype selective N-Methyl-D-Aspartate antagonists
8. 6455698 - Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents
9. 6417396 - Quenching reagents for solution phase synthesis
10. 6395930 - Quenching reagents for solution phase synthesis
11. 6340758 - Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents
12. 6268366 - Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
13. 6191134 - Amide derivatives of substituted quinoxaline 2, 3-diones as glutamate receptor antagonists
14. 6172065 - Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
15. 6121488 - Quenching reagents for solution phase synthesis